hexamethonium has been researched along with Esophageal Reflux in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pirenzepine was more potent than atropine and 4-DAMP." | 1.35 | Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux. ( Advenier, C; Chen, HZ; Cui, YY; Devillier, P; Wang, H; Zhu, L, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, YY | 1 |
| Zhu, L | 1 |
| Wang, H | 1 |
| Advenier, C | 1 |
| Chen, HZ | 1 |
| Devillier, P | 1 |
1 other study available for hexamethonium and Esophageal Reflux
| Article | Year |
|---|---|
Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux.
Topics: Animals; Atropine; Capillary Permeability; Diamines; Female; Ganglionic Blockers; Gastroesophageal R | 2008 |